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ABSTRACT
According to the recruitment model of
transcriptional activation, an activator helps initiate
transcription by bringing the RNA polymerase to a
specific location on the DNA through interaction
with components of the transcriptional machinery.
However, it is difficult to isolate and define the
activities of specific activator–target pairs experi-
mentally through rearranging existing protein
parts. Here we designed and constructed an
RNA-based transcriptional activator to study
specificity from both sides of the activator–target
interface. Utilizing a well-characterized site-specific
RNA aptamer for TFIIB, we were able to delineate
some key features of this process. By rationally con-
verting an inhibitory aptamer into the activation
domain of the activator, we also introduced a new
source of submolecular building blocks to synthetic
biology.
INTRODUCTION
In eukaryotic organisms, genes encoding messenger RNA
are transcribed by RNA polymerase II (Pol II) with the
help of general transcription factors (GTFs) (1). To
initiate transcription, the TATA-binding protein (TBP)
ﬁrst binds to DNA. Next, TFIIA and TFIIB bind to
TBP and the core promoter, followed by TFIIF and Pol
II. Finally, TFIIE and TFIIH join to complete the
assembly of a Pre-Initiation Complex (PIC) (2,3). In
addition, transcription of most genes requires activators,
because the formation of chromatin makes the
transcriptional ground state restrictive (4). There are two
general mechanisms by which activators facilitate tran-
scription: directly through interacting with members of
the Pol II entourage or indirectly through altering
chromatin structure (5,6). In either case, the location at
which the activator binds to DNA determines which gene
is activated. Therefore, a transcription activator requires a
minimum of two domains, a DNA-binding domain and an
activation domain. According to the recruitment model,
the target of an activation domain is likely to be either a
GTF or a subunit of the Pol II complex. Among the
GTFs, TBP and TFIIB are most strongly implicated as
the targets of activators (5).
Although the general scheme of transcriptional activa-
tion by recruitment has been delineated in broad outline,
certain important details remain elusive due to experimen-
tal diﬃculties. For example, an activator often interacts
with multiple GTFs, and its eﬀect on a single factor is
therefore diﬃcult to isolate; artiﬁcial recruitment of a
single factor through fusion to a DNA-binding domain
does not yield any information about the site or sites on
the factor contacted by activators (5). Many protein
activators share a common amino-acid composition
rather than exhibiting similarity in sequence or structure
(7); many RNA sequences have been isolated based on
their capability to activate transcription, but the mecha-
nistic basis for this activity is unknown (8,9). Both obser-
vations raised questions regarding the speciﬁc features of
surface topography that are essential for the function of
an activation domain.
An understanding of the mechanism underlying a phe-
nomenon should enable the design and construction of
diﬀerent systems that are able to reproduce that phenom-
enon. Therefore, deliberate creation of novel molecules
with explicitly and strictly deﬁned biological function is
a reliable way to test our current knowledge. Following
this principle, in the present study we implemented the
mechanism of transcription activation by recruitment of
a GTF using an RNA molecule assembled from reﬁned
and standardized parts, especially those derived from
aptamers. To explore speciﬁcity inherent to both sides of
the activator–target interface, we made use of a
well-characterized site-speciﬁc aptamer as the activation
domain of a synthetic activator.
RNA aptamers are generated in an in vitro process
emulating Darwinian evolution (10,11). For many
proteins, aptamers with a dissociation constant in the
nanomolar range have been isolated. Because selection
of an aptamer based on aﬃnity for its target is performed
outside the cellular and organismal milieu, the aptamer
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introduced into a living system (12). Consequently,
aptamers are routinely used as inhibitors of protein
activity. Here we attempted to rationally convert this
passive role of aptamers into an active one by placing an
aptamer in a designed molecular context, in which it func-
tions as one of several intentionally chosen interacting
sites.
In particular, we constructed a ‘transcription activator
RNA (taRNA)’ in the yeast Saccharomyces cerevisiae,
analogous to a protein-based activator. Using a set of
modular parts in a combinatorial manner, we speciﬁcally
implemented the mechanism of transcriptional activation
by recruiting TFIIB to the promoter of reporter genes in
the chromatin environment. For this purpose, an RNA
aptamer for TFIIB (13), which is a potent inhibitor of
transcription by default, was converted into the activation
domain of the taRNA by design. With the help of several
other constructs originally designed for the yeast
three-hybrid system (14), we were able to show that this
synthetic RNA molecule activated transcription at a level
comparable to a protein activator. Comparing the results
obtained by creating new RNA-based factors with those
obtained by reorganizing existing protein-based factors
allowed us to highlight some critical features of this
mechanism.
MATERIALS AND METHODS
Yeast strain and media
The S. cerevisiae strain YBZ-1 (MATa, ura3-52, leu2-3,
112, his3-200, trp1-1, ade2, LYS2::(LexA op)-HIS3,
ura3::(LexA op)-LacZ, LexA-MS2-MS2 coat (N55K))
was a gift from Professor Marvin Wickens (University
of Wisconsin, Madison) (14). Media consisted of yeast
nitrogen base (USBiological), 2% glucose, and synthetic
drop-out supplements lacking histidine or histidine and
uracil (USBiological). Transformation was performed
according to standard protocol using lithium acetate.
Yeast were cultured either on agar plates or in liquid
medium at 30 C if not otherwise indicated. Growth rate
in liquid media was measured by cell density through
turbidity at O.D. 600.
Construction of plasmids
The plasmids pIIIA/IRE-MS2 and pAD-IRP, were gifts
from Professor Wickens. The plasmid pDB-sansA was
derived from pIIIA/MS2-1 (14) by means of the following
manipulations. First, the unique NotI site was destroyed
by digesting with NotI, then the sticky ends were ﬁlled in
using the Klenow fragment of DNA polymerase I, and the
blunt ends were re-ligated. Second, the EcoRI fragment
was removed and replaced with the following sequence
containing a NotI site (bold and underlined): 50-ACTTG
AGGTCTGGGCTAAGCCCACTGATGAGTCGCTG
AAATGCGACGAAACCTCGAGTCATACTCGCGGC
CGCGAGGCGGCAGTATTCCGGTTCGCGCAGAA
ACATGAGGATCACCCATGTCCTGTGCCACAGCG
GTGAAACATGAGGATCACCCATGTCCACCAGC
GTTCCGGAGTACTGCCGTGACTCGACGTCTAGC
GATGTGGTTTCGCTACTGATGAGTCCGTGAGGA
CGAAACGTCGAC-30.
The plasmids encoding taRNA and its derivatives were
constructed by inserting a NotI fragment into the
pDB-sansA vector. Each plasmid and the RNA it
encoded were named after the standardized aptamer or
aptamer derivative being engrafted to the ‘DB-sansA’
scaﬀold (e.g. the taRNA is ‘DB-B4’ encoded by the
plasmid ‘pDB-B4’). The positive control was derived
from the RNA-based transcription activator m26-29 (9)
with the insert sequence 50-CGACTCTAGAGGATCGC
TTCGGCGGCTAGAACTAGTGGATCCCCCGGGC
GCGGAAGATTGTTCCCCCAAGTGGATGCCTAAA
CCTCATGCAT-30. The sequences of other inserts are
each listed below after the name of plasmid. pDB-B4:
50-AGCTAATGTAGGATGCTGGGGTAGTCCAGCC
CTAGAATAAGCGCTAGTACTACAAGCT-30. pDB-
B4mutS: 50-AGCTAATGTAGGATGCTGGCTTCGGC
CAGCCCTAGAATAAGCGCTAGTACTACAAGC
T-30. pDB-B4mutL: 50-AGCTAATGTAGGATGCTGG
GGTAGTCCAGCCCTAGCTTCGGCTAGTACTACA
AGCT-30. pDB-B4rev: 50-AGCTTGTAGTACTAGCGC
TTATTCTAGGGCTGGACTACCCCAGCATCCTAC
ATTAGCT-30. pDB-B60: 50-GGGAGAATTCAACTGC
CATCTAGGCGGTGATCGCACAGACACGGGCAC
TGATGCGGCTCCC-30. pDB-TBP12: 50-GCCGTGCC
CGGTTTGGATAGGCACATAAGAC-30. pDB-
TBP101: 50-AGAATTCAACTCTTCGGAGCCAAGGT
AAACAATTCAGTTAGTGGAATGAAACTG-30.
pDB-FC: 50-TCGCTCACGATACAGCACTGATTGCG
GTCGATGGTAGCGTTGATGGGCCACGCGCG
A-30. pDB-RA1: 50-GAATTCAACTGCCTTCGGGCAT
CGCGATACAAAATTAAGTTGAACGCGAGTTC-30.
Inserts were prepared by bi-directional extension of
overlapping oligonucleotides. All synthetic oligonu-
cleotides were purchased from Integrated DNA
Technologies, Inc.
Secondary structure prediction and conﬁrmation
Secondary structures of RNA constructs were predicted
using the mfold program (v. 3.2) (15). To identify a
stable stem as the point of integration, a series of deriva-
tives were constructed based on the most thermodynami-
cally stable predicted structure of an aptamer and tested
for binding activity (16).
Assays for b-galactosidase activity
The ﬁlter assay was performed as described in (17). The
colonies were lifted from the plate using nitrocellulose
ﬁlters (Millipore). Cells were permeabilized by freezing
the ﬁlter in liquid N2. The enzymatic reaction was initiated
by overlying the ﬁlter on a piece of Whatman 3MM paper
saturated with X-gal containing Z buﬀer (60mM
Na2HPO4, 60mM NaH2PO4, 10mM KCl, 1mM
MgSO4, and 1mg/ml X-gal), and allowed to proceed for
30min. For the quantitative liquid assay, a standard
protocol (18) was followed using O-nitrophenyl-b-D-
galactopyranoside (ONPG) as the substrate. Activity
was calculated as Miller units and normalized to the
Gal4-based positive control for the three-hybrid system
Nucleic Acids Research,2010, Vol.38, No. 7 2379(14). At least three independent cultures of each construct
were measured.
Single cell analysis
Continuous optical measurements of individual localized
cells were performed on a microﬂuidic gridded array, the
LiveCell Array (Molecular Cytomics), with a standard
microscope (Olympus) (19). A 500-ml aliquot of cell sus-
pension was combined with a 500-ml aliquot of 250mg/ml
Concanavalin A-Tetramethylrhodamine (ConA-
TAMRA) conjugate, a labeling reagent that allowed the
cells’ position to be registered. The cells were washed with
media and loaded onto the array. The microﬂuidic
chamber enabled addition of the substrate 5-dodecanoy-
laminoﬂuorescein di-b-D-galactopyranoside (C12FDG,
Molecular Probes) in media to the localized cells. The
measurements were taken with optical ﬁlter systems
speciﬁc for ﬂuorescein (C12FDG) and TAMRA.
RESULTS
Mechanism-driven choice and reﬁnement of an aptamer
Based on the recruitment model of PIC assembly, we
surveyed published aptamers to ﬁnd a candidate that
would function as an activation domain when tethered
to a promoter. Five aptamers were identiﬁed: one for
Pol II, two for TBP, and two for TFIIB. All of these
aptamers showed inhibitory eﬀects on transcription
either in vitro or in vivo. Four of them were deemed
unﬁt to act as an activator based on the following mech-
anistic information. First, the aptamer for the Pol II, FC
(20), binds in the Pol II active center cleft and prevents the
DNA template from entering (21). Therefore, FC would
not be able to activate transcription even if it were used to
bring Pol II to a promoter. Second, the two aptamers for
TBP, AptTBP-12 and AptTBP-101, recognize two discrete
sites respectively (16,22). Both inhibit transcription by pre-
venting PIC formation, although in mechanistically dis-
tinctive ways attributable to their speciﬁc binding sites
(16). Third, one of the aptamers for TFIIB, AptTFIIB-
60, inhibits transcription by preventing the incorporation
of TFIIB into the PIC (13).
Intriguingly, the other TFIIB aptamer, AptTFIIB-4,
inhibitory as it is, does not aﬀect TFIIB occupancy at
the PIC, nor does it aﬀect TBP and TFIIA levels on a
template (13). Therefore, AptTFIIB-4 met our design
criteria and was chosen as the putative activation
domain. Because it binds only TFIIB and not any other
factor, its target in the Pol II machinery can be precisely
assigned. Because it does not prevent TFIIB from being
incorporated into the PIC, when tethered to a promoter
we presumed AptTFIIB-4 would activate transcription
either through recruitment of TFIIB to the PIC or
through stabilization of a pre-bound complex on DNA.
Because AptTFIIB-4 alone is inhibitory, its tethered form
must activate transcription through the recruitment of
TFIIB rather than by stabilizing the pre-formed PIC.
Viewed retrospectively, the assay for the eﬀect of the
aptamer on in vitro transcription (13) was analogous to
in vivo ‘squelching’ experiments (23,24), thus excluding the
possibility of activation through PIC stabilization. Taken
together, this speciﬁc functional information allowed us to
implement the predetermined mechanism from the bottom
up.
The ﬁrst step of this implementation was to reﬁne the
‘raw’ aptamer into a standardized portable submolecular
module. As we did before for other aptamers (16), we
made a series of mutations of AptTFIIB-4 to map the
‘true’ aptamer moiety and identify a stable stem as the
point of integration (see Supplementary Data for
details). This led to the proposed secondary structure
depicted in Figure 1A, where the sequence and structure
enclosed in the rectangular box is necessary and suﬃcient
for TFIIB binding. This minimized version of the aptamer
was composed of a three-way junction, exiting from which
were two stem loops (‘S’ and ‘L’) and a stem with an open
end (Figure 1B). To the open stem we added a ‘GC-clamp’
(25) by pairing the 50 and 30 termini, which served as a
standardized interface with the rest of the composite
molecule.
Molecular and genetic design
We converted the inhibitory AptTFIIB-4 into the activa-
tion domain of the taRNA by providing its minimized
L
B4
B4mutS
B4mutL
B4rev
A
B
S
Figure 1. AptTFIIB-4 and its derivatives. (A) Predicted secondary
structure of AptTFIIB-4. The structure was generated by mfold and
supported by mutational analysis. The box indicates the ‘B4’ aptamer
moiety. (B) Standardized aptamer B4 and its derivatives. The ‘S’ and
‘L’ loops are indicated in B4. The boxes indicate the identical
GC-clamp in each structure.
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molecular context (Figure 2A). To integrate it into the
cellular regulatory network, the taRNA was produced
by transcription from a synthetic gene. Both the taRNA
and its expression system were designed using a modular
approach, with each part previously tested individually in
vivo. To design the composite taRNA molecule, we
employed a method described elsewhere, which allows
the use of a library of parts with a common junction at
the submolecular level to simplify the prediction of
function when the parts are combined (26). Speciﬁcally,
the taRNA was composed of four functional elements—
the B4 aptamer, two copies of the MS2 coat protein
ligand, and a hybrid hammerhead ribozyme—connected
in a single molecular entity through two three-way junc-
tions (Figure 2B).
Protein activators achieve their sequence-speciﬁc asso-
ciation with DNA either directly through a DNA-binding
domain [e.g. yeast Gal4 (27)] or indirectly through an
adaptor protein [e.g. VP16 of herpes simplex virus (28)].
For the taRNA we took the latter strategy: instead of a
direct DNA–RNA interface, we employed a LexA-MS2
coat protein fusion construct that had been previously
used to localize RNA to DNA through more speciﬁc
DNA–protein and protein–RNA recognition (29). As an
indirect DNA association domain, we used a dimeric con-
ﬁguration of the coat protein ligand to improve its avidity
to the MS2 coat protein.
To express the taRNA we designed a transcriptional
unit driven by RNA polymerase III (Pol III), as TFIIB
is not involved in Pol III transcription and its aptamer
would not aﬀect the production of the taRNA. In
addition to the coding region, the synthetic gene
comprised the promoter and terminator of the RNase P
RNA gene RPR1 (30). The same promoter–terminator
system was used previously to express the aptamer FC,
but failed to generate a detectable growth phenotype
(20), suggesting that the taRNA thus produced would be
kept at an appropriate level without causing systemic
eﬀects (e.g. squelching). However, the RPR1 promoter is
intragenic, and in the FC construct the leader sequence
was not cleaved oﬀ (20). Also carried on the transcript is
part of the terminator sequence including a stretch of
uridines. To eliminate these ﬂanking sequences, we used
two cis-acting hammerhead ribozymes known to be func-
tional in vivo (31) (also see Supplementary Data).
After self-cleavage, the 30 half of the 50 ribozyme and the
50 half of the 30 ribozyme would form a new ‘hybrid ham-
merhead ribozyme’, which is part of the taRNA shown in
Figure 2B. Because it is not poly-adenylated, the taRNA
would be retained inside the nuclei as we demonstrated
previously (12). Inside cells most RNA molecules are
degraded by exonucleases that digest single-stranded
RNA. Enhanced stability has been demonstrated by
conﬁning the termini of an RNA in a double-stranded
stem (termed S35) (32). The Stem III of the hybrid
ribozyme was such an S35 (Figure 2B). The hammerhead
ribozyme cleaves the RNA backbone to yield a 50
hydroxyl and a 20,3 0 cyclic phosphodiester; under
certain conditions it might ligate these products using
the bond energy retained in the non-hydrolyzed cyclic
product to re-form a phosphodiester (33).
Sequences encoding all parts of the taRNA except the
activation domain were embedded in the yeast/Escherichia
coli shuttle vector pDB-sansA, which produced an RNA
construct with DNA-binding (DB) activity conferred by
A
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“Indirect” DNA binding domain
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DNA fragment
In vector
RNA transcript
Processed RNA
S35
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LexA op
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RNA Pol II & other factors
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HIS3
Figure 2. Molecular and genetic design of taRNA. (A) Schematic
diagram showing the function of the taRNA. (B) The most stable
structure of the taRNA as predicted by mfold. Each structural and
functional unit is indicated by a circle or a rectangle, with the name
of the element next to it. The three-way junction connecting the two
MS2 coat protein ligands was derived from the 5S rRNA of
H. marismortui (47). The other three-way junction was a stable 5S
rRNA variant named ‘System F’ (48). (C) Schematic diagram depicting
the EcoRI segment in the pDB series of plasmids before and after
subcloning, and the RNA transcribed from the synthetic gene before
and after further processing by hammerhead ribozyme cleavage. The
DNA and RNA segments are aligned to show their relationship. The
two ribozymes were taken from peach latent mosaic viroid (PLMVd)
and tobacco ringspot virus satellite RNA (sTRSV), respectively (31).
The cleavage sites of the ribozymes are indicated by arrowheads.
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(hence ‘sansA’). Figure 2C depicts a section of the
vector between the two EcoRI sites, in alignment with
the corresponding RNA transcript before and after
ribozyme cleavage. The taRNA gene was generated by
inserting the B4 sequence through subcloning into a
NotI site to form a ‘DB-B4’ construct. The two resulting
NotI sequences would form a GC-clamp to insulate the
incoming aptamer from the rest of the molecule to ensure
its correct folding. Alternative aptamers and positive or
negative control units were also added to the ‘DB-sansA’
scaﬀold through this standardized procedure.
Activity of the transcription activator RNA
The taRNA activity was measured through the transcrip-
tion of reporter genes under the control of LexA opera-
tors, with the help of a LexA-MS2 coat protein fusion
adaptor. The yeast strain YBZ-1, designed for the
three-hybrid system, contains both the reporters and the
adaptor. Importantly, the reporter genes HIS3 and lacZ
are in the chromatin environment (14). To verify the
predetermined function of the activation domain in the
taRNA, we employed a positive control along with a
battery of negative controls. For the positive control, we
used the RNA-based transcription activator m26-29 (9).
This RNA was selected for its capability of activating
transcription, but its target and mechanism are
unknown. Our ﬁrst negative control was the antisense
sequence of B4 (B4rev)—a ‘DB-B4rev’ construct was a
cloning byproduct of the taRNA. As shown in
Figure 1B, B4rev was able to form a secondary structure
similar to B4. We also generated two other negative
controls, B4mutS and B4mutL, by replacing one of the
two loops of B4 with a UUCG-tetraloop. The ‘empty’
vector also served as a negative control as it would
produce the ‘DB-sansA’ RNA analogous to an activation
domain deletion.
After transformation, the expression of the RNA con-
structs in each yeast strain was conﬁrmed by RT–PCR
(Supplementary Data), and the transformants expressing
the taRNA and the controls were plated at 30 C on media
with or without histidine. As shown in Figure 3A, all
strains grew equally well on the plate with histidine,
indicating that, as predicted, taRNA at this level of
expression had no signiﬁcant systemic eﬀect. In contrast,
on the plate without histidine, only strains expressing the
taRNA or the positive control DB-m26-29 were able to
survive. To conﬁrm this result, we performed two more
assays. First, we added increasing amounts of
3-aminotriazole (3-AT), a competitive inhibitor of His3p
activity, to the his- medium to test the strength of the
taRNA. As shown in Figure 3A, in media containing
5mM 3-AT, some yeast colonies expressing the taRNA
were still able to grow. Second, we measured the growth
rate of these strains in liquid media. As shown in
Figure 3B, the taRNA was able to sustain a growth rate
comparable to DB-m26-29, although none of the negative
controls grew without histidine.
As an alternative and independent reporter gene we
used lacZ, the activity of whose product is easier to
quantify. First, we measured the b-galactosidase activity
using a qualitative ﬁlter assay (17). As shown in
Figure 4A, permeabilized cells in yeast colonies expressing
the taRNA or the positive control were able to convert
X-gal to produce a blue color, but all the negative controls
lacked this capability. To quantify the speciﬁc activity of
b-galactosidase, we next used a liquid assay with cell
lysates and ONPG (18). As a benchmark, we compared
the activity of taRNA to the positive control used in the
three-hybrid screening, in which a Gal4 activation domain
is tethered to DNA using the binding of the iron regula-
tory protein 1 (IRP1) to the iron response element (IRE)
(29). As shown in Figure 4B, the taRNA has activity more
than 2-fold greater than this control.
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Figure 3. Activity of the taRNA as measured by the HIS3 reporter
gene transcription. (A) Growth on agar plates. Each strain is identiﬁed
by the molecular construct it harbors and its position on the plates is
indicated in the drawing (upper left). The upper right plate is a control
plate (ura , his+) demonstrating that all strains are viable and grow at
a normal rate in the absence of selection for HIS3. The two lower
plates lack histidine. The lower right plate also contains 5mM 3-AT.
(B) Growth curves measured in liquid media lacking histidine. Values
represent the average of three independent cultures of each strain. Error
bars show standard deviations.
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determined the b-galactosidase activity in living cells
using optical arrays of single cells (19) with the
chromogenic substrate C12FDG. The substrate contains
a lipophilic tail enabling its entry into the cell. Once pro-
cessed by the enzyme, this tail is lost, and a ﬂuorescent
product is trapped inside the cell. This assay allowed
examination of cells individually under identical condi-
tions. As shown in Figure 4C, the taRNA cells exhibited
minimal heterogeneity. The standard deviations
associated with the optical signal responses across the
population were less than 2% of the measured signal
intensity.
Speciﬁcity of the transcription activator RNA
Whereas B4 was the main focus of the present study, we
used other aptamers for components of the Pol II machin-
ery to help clarify and corroborate our mechanistic claims
by comparing and contrasting their eﬀects with those of
B4’s. As shown in Figure 5A, we reﬁned four other
aptamers for TBP, TFIIB, or Pol II by trimming their
sequences and converting them to the standardized
form. Our modular design allowed rapid and easy
addition of these standardized aptamers to the
DB-sansA scaﬀold. As predicted, none of these aptamers
were able to function as an activation domain
(Figure. 5B). While the failure of FC, which binds the
active cleft of Pol II, provides a straightforward illustra-
tion of the importance of the binding site on the target
(21), the other three constructs aﬀorded more subtle
insights. Both TBP and TFIIB are primary targets of tran-
scription activators, yet simply recruiting them to the
promoter was not enough to activate transcription. In
the case of TBP, fusion with a DNA-binding domain
was able to activate (34–36), but recruitment through a
tethered aptamer was not. Presumably the fusion protein
was incorporated into the holoenzyme, but aptamer
binding prevented TBP from doing so, even when the
binding site on TBP is the DNA-binding surface (16). A
more interesting case is TFIIB. Both B4 and AptTFIIB-60
bind to TFIIB with similar aﬃnity, and their contact sites
overlap on the c-terminal core domain (cIIB) at or close to
the linker region (13). Transcription activators such as
Pho4 have also been shown to bind cIIB (37). However,
the two aptamers for TFIIB behaved diﬀerently both
in vitro and in vivo. Taken together, this collection of con-
structs demonstrated that the speciﬁc site of contact and
the mode of contact with the target were important for
activation to occur.
Finally, we attempted to use these newly acquired mech-
anistic insights to build another aptamer-based transcrip-
tion activator with a speciﬁed target. Previously, we
isolated an RNA aptamer for the heat-shock factor
(HSF) (38). HSF recognizes the heat-shock elements on
DNA and upon heat shock activates transcription by
recruiting other factors or complexes to the promoter.
The aptamer, AptHSF-RA1, binds to the HSF
DNA-binding domain and the linker region but not the
domains involved in trimerization and activation.
Therefore, we reasoned that AptHSF-RA1 might be
used to recruit HSF to a non-heat-shock promoter. Not
being occluded by the aptamer, the activation domain of
the HSF would remain functional. Indeed, when we
expressed a DB-RA1 construct (AptHSF-RA1 in the
pDB-sansA vector) in yeast, we observed transcription
activation of both reporter genes at a moderate level,
lower than that produced by the taRNA but signiﬁcantly
above the background level (Figure 5B). However, this
activity was indiﬀerent to temperature change.
Apparently, recruiting HSF this way was not able to
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Figure 4. Activity of the taRNA as measured by b-galactosidase
activity. (A) Qualitative ﬁlter lift assay of permeabilized cells from a
ura-, his- plate using X-gal. (B) Quantitative colorimetric assay of cell
lysate using ONPG. The average activity of each strain is shown
normalized relative to the Gal4 three-hybrid positive control
(IRE-MS2+AD-IRP) (29). Error bars show standard deviations.
(C) Optical array analysis of living single cells using C12FDG.
A total of 114 cells were measured one and two hours after adding
the substrate. The inset shows a section of the array.
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modiﬁcation at the promoter (39). Nonetheless, the
activity we observed lends further support to the mecha-
nism of recruitment illustrated by the B4-derived taRNA.
DISCUSSION
In this study, we took a forward engineering approach to
synthesize a transcription activator to implement the
mechanism of transcription activation by recruitment of
a GTF. By comparing the expected and observed behavior
of the designed molecules, we were able not only to
validate this mechanism, but also to investigate the
speciﬁcity between an activator and its target. In the
future, the taRNA will be used as a model to study
the events that occur in the process of transcription acti-
vation after the B4 associates with TFIIB.
Our work was greatly facilitated by existing constructs
originally designed for the yeast three-hybrid screening
(14). However, there is a fundamental diﬀerence between
our work and the three-hybrid system. The general utility
of the three-hybrid system lies in the fact that
transcriptional activation in this system relies on the
physical rather than the biological properties of the
RNA (29). Numerous types of RNA–protein interactions,
including the binding speciﬁcity of aptamers, have been
analyzed using this system, regardless of the normal
function of the RNA molecule (40,41). In contrast, here
the taRNA was designed to provide the biological
function and integrate itself into the functional context
of PIC formation. This diﬀerence can be appreciated by
comparing our work with a recently published study (42).
In this elegant piece of work, as well as similar works from
the same group (25,43), an RNA aptamer was also
involved and the target of the aptamer was also a tran-
scription factor. However, the B4 aptamer in our con-
struct is functionally not analogous to the anti-NF-kB
aptamer, but instead analogous to the GAL4 activation
domain in their system.
In order to regulate biological processes, proteins and
other molecules associate with each other through a
complex network of interactions. Modiﬁcation of the
network connectivity forms the basis of experimental per-
turbation and therapeutic intervention. Traditional
methods modify such connectivity by blocking or abolish-
ing molecular interactions. Following this strategy, RNA
aptamers have been used as protein antagonists for more
than a decade (44). An alternative and possibly more eﬀec-
tive strategy is to introduce new links between
non-interacting molecules. This concept is rarely used
because bridging two molecules speciﬁcally and selectively
is substantially more diﬃcult than blocking one molecule.
A recent study converted a monomeric aptamer into a
non-covalent homodimer functioning as an agonist by
inducing the targets to multimerize (45). Diﬀering from
this approach, our implementation of the aptamer-based
taRNA can be viewed as a molecular surgery that
‘rewired’ the connectivity of an existing regulatory
network to bypass a native activator.
By transﬁguring an inhibitory RNA aptamer into an
activation domain and constructing covalent composites
using a modular and combinatorial procedure, we have
expanded the utility of aptamers and introduced a new
type of building blocks, or ‘synthons,’ for use in synthetic
biology. Like proteins, RNA can form complex structures
with sophisticated functions, although these are used only
occasionally by contemporary organisms. Most cellular
functions are actualized by proteins because proteins
possess two distinctive characteristics: ﬁrst, a single
protein molecule is capable of bearing more than three
sites recognizable speciﬁcally by other molecules, collec-
tively forming a scale-free network (46); second, proteins
can be genetically encoded, and their biosynthesis and
degradation can be regulated by environmental and
developmental cues. To realize the potential of RNA, we
designed novel molecules to be ‘protein-like’ in these two
fundamental aspects. This type of RNA construct is easier
to design than novel protein molecules and has much less
B
A
X-gal
His+ His-
Figure 5. Speciﬁcity of the taRNA. (A) Secondary structures of ﬁve
reﬁned and standardized aptamers. Boxes indicate the identical
GC-clamp in each structure. (B) Capability or lack thereof of each
aptamer to function as an activation domain, as assayed by HIS3
reporter gene transcription and b-galactosidase activity.
2384 Nucleic Acids Research, 2010,Vol.38, No. 7immunogenicity when used in vivo. Based on these
features, we envision that more engineered biological
systems will make use of composite RNA aptamers to
empower design-based predictive modiﬁcation of organ-
isms.
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